Add-on Pentoxifylline to Losartan Versus Increasing Dose of Losartan on NT-PRO BNP in Type 2 Diabetics With Nephropathy

NCT03006952 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

59

Enrollment

OTHER

Sponsor class

Conditions

Diabetic Nephropathies

Interventions

DRUG: Pentoxifylline
DRUG: Losartan

Sponsor

Tehran University of Medical Sciences